Page last updated: 2024-11-11

tb 450

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

TB 450: each tablet contains 300 mg isoniazid & 150 mg of thioacetazone; commonly used for treatment of tuberculosis & for leprosy in combination with diaminodiphenylsulfone [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9574757
MeSH IDM0091892

Synonyms (11)

Synonym
n-[4-[(e)-(carbamothioylhydrazono)methyl]phenyl]acetamide; pyridine-4-carbohydrazide
isoniazid & thiacetazone
tb 450
thiazina
isazone
tb-450
isozone
4-pyridinecarboxylic acid, hydrazide, mixt. with n-(4-(((aminothioxomethyl)hydrazono)methyl)phenyl)acetamide
62682-46-6
DTXSID70211747
n-[4-[(e)-(carbamothioylhydrazinylidene)methyl]phenyl]acetamide;pyridine-4-carbohydrazide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (71.43)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.75 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index32.77 (26.88)
Search Engine Supply Index2.31 (0.95)

This Compound (27.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (28.57%)4.05%
Observational0 (0.00%)0.25%
Other4 (57.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]